New president and CEO at Catalent
This article was originally published in Scrip
Executive Summary
Catalent Pharma Solutions (US), a provider of development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies, has appointed John Chiminski president and chief executive officer. George Fotiades, who has been serving as interim president and CEO, will step down from the role, but will continue to serve as chairman of Catalent's board. Mr Chiminski most recently served as president and CEO of GE Medical Diagnostics.